pyrazinamide has been researched along with Optic Neuritis in 3 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
Optic Neuritis: Inflammation of the optic nerve. Commonly associated conditions include autoimmune disorders such as MULTIPLE SCLEROSIS, infections, and granulomatous diseases. Clinical features include retro-orbital pain that is aggravated by eye movement, loss of color vision, and contrast sensitivity that may progress to severe visual loss, an afferent pupillary defect (Marcus-Gunn pupil), and in some instances optic disc hyperemia and swelling. Inflammation may occur in the portion of the nerve within the globe (neuropapillitis or anterior optic neuritis) or the portion behind the globe (retrobulbar neuritis or posterior optic neuritis).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yates, WB | 1 |
| Nothling, S | 1 |
| Lawlor, M | 1 |
| Laktaoui, A | 1 |
| Naoumi, A | 1 |
| Reda, K | 1 |
| Kriet, M | 1 |
| Elouarsani, A | 1 |
| Khayati, A | 1 |
| Elharradi, A | 1 |
| Rouimi, A | 1 |
| Douhal, A | 1 |
| Mounahc, J | 1 |
| Houmadi, A | 1 |
| Durrheim, DN | 1 |
| Belt, EL | 1 |
3 other studies available for pyrazinamide and Optic Neuritis
| Article | Year |
|---|---|
Optic Perineuritis Due to Tuberculosis.
Topics: Adult; Antitubercular Agents; Bronchoscopy; Drug Therapy, Combination; Humans; Isoniazid; Magnetic R | 2019 |
[Macular tuberculoma and optic neuritis: rare association with tuberculosis meningoencephalitis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antitubercular Agents; Calcinosis; Confusion; Dip | 2009 |
Tuberculosis control programme guidelines--treatment regimens.
Topics: Antitubercular Agents; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Ethambutol; | 1996 |